0.00Open0.33Pre Close0 Volume234 Open Interest76.00Strike Price0.00Turnover236.38%IV5.46%PremiumDec 27, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.33Extrinsic Value100Contract SizeAmericanOptions Type-0.1543Delta0.0593Gamma242.55Leverage Ratio-2.8931Theta-0.0001Rho-37.43Eff Leverage0.0040Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet